Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,607 | 94 | 89.8% |
| Education | $411.43 | 5 | 10.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $1,223 | 27 | $0 (2024) |
| Gilead Sciences, Inc. | $1,056 | 17 | $0 (2021) |
| Janssen Products, LP | $565.11 | 6 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $408.46 | 25 | $0 (2021) |
| Esperion Therapeutics, Inc. | $124.59 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $124.58 | 1 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $113.59 | 1 | $0 (2017) |
| Neuronetics, Inc. | $95.13 | 5 | $0 (2022) |
| Janssen Biotech, Inc. | $50.98 | 2 | $0 (2022) |
| ABBVIE INC. | $42.72 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $176.83 | 6 | ViiV Healthcare Company ($153.84) |
| 2023 | $191.67 | 6 | ViiV Healthcare Company ($133.96) |
| 2022 | $526.42 | 14 | ViiV Healthcare Company ($179.34) |
| 2021 | $860.67 | 15 | ViiV Healthcare Company ($439.87) |
| 2020 | $94.60 | 6 | ViiV Healthcare Company ($68.80) |
| 2019 | $685.28 | 16 | Gilead Sciences, Inc. ($368.85) |
| 2018 | $463.06 | 17 | Gilead Sciences, Inc. ($266.73) |
| 2017 | $1,020 | 19 | Gilead Sciences Inc ($310.63) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $112.70 | General |
| Category: HIV | ||||||
| 08/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/10/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $2.71 | General |
| Category: HIV | ||||||
| 04/12/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: HIV | ||||||
| 02/28/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: HIV | ||||||
| 02/14/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: HIV | ||||||
| 11/01/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: HIV | ||||||
| 10/20/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Endocrinology | ||||||
| 07/31/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: ETONOGESTREL | ||||||
| 04/26/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: ETONOGESTREL | ||||||
| 04/20/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: HIV | ||||||
| 11/15/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: HIV | ||||||
| 10/13/2022 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $18.43 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 08/25/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $8.91 | General |
| Category: HIV | ||||||
| 08/24/2022 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $14.17 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 08/24/2022 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $14.17 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 08/01/2022 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $24.18 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 08/01/2022 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $24.18 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 06/13/2022 | Janssen Products, LP | SYMTUZA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/19/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HIV | ||||||
| 03/30/2022 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $28.37 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 03/17/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: HIV | ||||||
| 03/09/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/10/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 955 | 1,562 | $304,632 | $115,115 |
| 2022 | 40 | 1,772 | 2,235 | $364,758 | $144,488 |
| 2021 | 28 | 1,600 | 1,963 | $268,286 | $112,491 |
| 2020 | 5 | 89 | 135 | $40,347 | $9,055 |
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 399 | $108,999 | $40,010 | 36.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 76 | 76 | $22,828 | $11,322 | 49.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 57 | 58 | $22,967 | $10,036 | 43.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 55 | 56 | $29,848 | $9,810 | 32.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 26 | 125 | $15,625 | $5,387 | 34.5% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 67 | 68 | $15,980 | $5,244 | 32.8% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 46 | 47 | $14,382 | $4,708 | 32.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 16 | 96 | $9,600 | $4,149 | 43.2% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 37 | 38 | $11,286 | $3,819 | 33.8% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 19 | 19 | $9,576 | $3,324 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 48 | $8,640 | $3,283 | 38.0% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 14 | 81 | $4,860 | $2,904 | 59.8% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 26 | 27 | $9,909 | $2,852 | 28.8% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 27 | 28 | $6,132 | $2,222 | 36.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 110 | 199 | $2,985 | $1,663 | 55.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 16 | 17 | $2,125 | $1,284 | 60.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 46 | 46 | $2,208 | $992.22 | 44.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 66 | 70 | $3,390 | $879.21 | 25.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 34 | 34 | $1,632 | $733.38 | 44.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 13 | 13 | $1,235 | $282.04 | 22.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 13 | 17 | $425.00 | $209.95 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 303 | $82,719 | $29,532 | 35.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 61 | 62 | $36,766 | $10,857 | 29.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 69 | 69 | $20,493 | $10,637 | 51.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 47 | 47 | $25,051 | $8,674 | 34.6% |
About Dr. Steven Golinowski, D.O
Dr. Steven Golinowski, D.O is a Family Medicine healthcare provider based in Massapequa, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528092020.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Golinowski, D.O has received a total of $4,019 in payments from pharmaceutical and medical device companies, with $176.83 received in 2024. These payments were reported across 99 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,607).
As a Medicare-enrolled provider, Golinowski has provided services to 4,416 Medicare beneficiaries, totaling 5,895 services with total Medicare billing of $381,149. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Massapequa, NY
- Active Since 07/10/2006
- Last Updated 10/25/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1528092020
Products in Payments
- DOVATO (Drug) $826.97
- ISENTRESS (Drug) $336.46
- Biktarvy (Drug) $250.00
- Truvada (Drug) $236.79
- SYMTUZA (Drug) $234.98
- Symtuza (Drug) $182.39
- CABENUVA (Biological) $148.84
- NEXLIZET (Drug) $124.59
- FARXIGA (Drug) $124.58
- JULUCA (Drug) $115.76
- SOLIQUA (Drug) $113.59
- TRIUMEQ (Drug) $113.55
- PREZCOBIX (Drug) $99.00
- NEUROSTAR TMS THERAPY SYSTEM (Device) $95.13
- Ozempic (Drug) $40.68
- NEXPLANON (Drug) $32.20
- IBSRELA (Drug) $22.99
- Dexcom G6 Transmitter (Medical Supply) $22.36
- Androgel (Drug) $22.11
- CONTRAVE (Drug) $21.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Massapequa
Stuart Horowitz, Do, DO
Family Medicine — Payments: $10,519
Jill Sisselman, D.o, D.O
Family Medicine — Payments: $7,137
Dr. Teresa Esposito, Do, DO
Family Medicine — Payments: $3,624
Richard Bebirian, Do, DO
Family Medicine — Payments: $2,792
Dr. Ching Yeh Lin, M.d, M.D
Family Medicine — Payments: $575.14
Dr. John Dimartino, Md, MD
Family Medicine — Payments: $45.02